265643-91-2

Basic information

• Product Name: [1,2,4]triazolo[1,5-a]pyridin-2-ylmethanol
• Synonyms: [1,2,4]triazolo[1,5-a]pyridin-2-ylmethanol
• CAS NO: 265643-91-2
• Molecular Formula: C7H7N3O
• Molecular Weight: 149.152
• Mol File: 265643-91-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: [1,2,4]triazolo[1,5-a]pyridin-2-ylmethanol(CAS DataBase Reference)
• NIST Chemistry Reference: [1,2,4]triazolo[1,5-a]pyridin-2-ylmethanol(265643-91-2)
• EPA Substance Registry System: [1,2,4]triazolo[1,5-a]pyridin-2-ylmethanol(265643-91-2)

Safety Data

• Hazardous Substances Data: 265643-91-2(Hazardous Substances Data)

Usage

General Description

[1,2,4]triazolo[1,5-a]pyridin-2-ylmethanol is a chemical compound with the chemical formula C8H7N3O. It is a heterocyclic compound that contains a triazole and pyridine ring. [1,2,4]triazolo[1,5-a]pyridin-2-ylmethanol has potential applications in the field of medicine and pharmaceuticals as it can have biological activity. It may be used in the development of new drugs, as well as in research and development of medicinal compounds. Its structure and properties make it a valuable compound for investigation and potential use in various medical applications.

Upstream product

• 62135-58-4 ethyl s-triazolo<1,5-a>pyridine-2-carboxylate 
• 504-29-0 2-aminopyridine 
• 96-35-5 glycolic acid methyl ester 
• 56000-35-2 1-aminopyridin-2(1H)-iminium-2,4,6-trimethylbenzenesulfonate 

Downstream Products

• 1373338-09-0 [1,2,4]Triazolo[1,5-a]pyridine-2-carbaldehyde 

Relevant articles and documents

INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF

The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

PDE10 MODULATORS

The present invention relates to compounds of formula (I) wherein R1, R2, R3, R5, W, X, X1, Y, Y1, Z and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as medicaments.

METABOTROPIC GLUTAMATE RECEPTOR MODULATORS

The invention relates to heterocyclic derivatives of formula (I) as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders wherein Y, W, R1, R2 and R3 are as defined in claim 1.